Cani L, Bringhen S, Piciocchi A, Giuliani N, Mangiacavalli S, Falcone A, Benevolo G, Capriata M, Vassallo F, Ciceri F, Pane F, Floris R, Cantonetti M, Pezzatti S, D’Agostino M, Casson A, Evangelista A, Saraci E, Mirabile M, Gamberi B, Conconi A, Pietrantuono G, Galieni P, Curci P, Margiotta-Casaluci G, Liso A, Scaldaferri M, Bruno B, Boccadoro M, Larocca A. P14 | DARATUMUMAB-BORTEZOMIB-MELPHALAN-PREDNISONE VS. DARATUMUMAB-LENALIDOMIDE-DEXAMETHASONE IN TRANSPLANT-INELIGIBLE REAL-LIFE PATIENTS WITH MULTIPLE MYELOMA: A SUBANALYSIS OF THE PHASE IV REAL MM TRIAL. Haematologica 2026; 111(s2); https://doi.org/10.3324/haematol.2026.s2.14052.